Matches in Nanopublications for { ?s ?p "LEXIVA is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection. The protease inhibitor-experienced patient study was not large enough to reach a definitive conclusion that LexIVA plus ritonavir and lopinavir are clinically equivalent [see Clinical Studies (14.2)" ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- assertion wasQuotedFrom "LEXIVA is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection. The protease inhibitor-experienced patient study was not large enough to reach a definitive conclusion that LexIVA plus ritonavir and lopinavir are clinically equivalent [see Clinical Studies (14.2)" provenance.